On a lush cricket ground outside Colombo the sharp jingling of a ball cuts through the afternoon air. Every rattle is a pushback against the stigma of disability.
Which players fell out of the top 10 in Nick Shook's QB Index rankings? Who jumped 16 spots? Check out the updated pecking ...
On 13 November 2025, Merck Sharp & Dohme LLC initiated a study is to learn if people who receive patritumab deruxtecan (also ...
A multinational company is taking a small-town Australian cleaner to court, claiming his glass-cleaning product is ...
Le Chant du Loup (The Wolf’s Call), a blockbuster involving a French nuclear submarine is being screened in Sri Lanka this ...
Libtayo plus chemotherapy is potentially more cost-effective than Keytruda plus chemotherapy for advanced NSCLC, offering lower costs and higher QALYs. The study's model, based on clinical trial data, ...
Synthekine Inc., an engineered cytokine therapeutics company, today announced that the company has dosed the first patient in the SYNERGY-101 study. SYNERGY-101 is a global, randomized Phase 2 ...
Mumbai doctors highlight, ahead of World Diabetes Day 2025 observed on November 14 every year, that more people need to do ...
Clinical Trials Arena on MSN
Synthekine reports initial STK-012 data in lung cancer trial
Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, programmed ...
GMRx2 is a combination tablet of telmisartan, an angiotensin II receptor blocker, amlodipine, a dihydropyridine calcium channel blocker and indapamide, a thiazide-like diuretic, available in three ...
The Spanish renewables-focused utility distributed nearly 189,000 gWh between January and September across its global portfolio, with growth in the UK and Spain. Image by Irene Miller via iStock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback